期刊文献+

表面活性剂对高水溶性药物阿魏酸钠白蛋白纳米粒的载药特性影响 被引量:3

Effects of surfactants on the pharmaceutical characteristics of bovine serum albumin nanoparticles of highly water-soluble drug sodium ferulate
下载PDF
导出
摘要 目的:制备高水溶性药物白蛋白纳米粒,考察表面活性剂对高水溶性药物的包封作用。方法:以牛血清白蛋白为载体材料,阿魏酸钠为高水溶性药物模型,采用去溶剂化法制备阿魏酸钠白蛋白纳米粒。用低温超速离心法、层析-离心法、层析-酶解法对纳米粒包封率和载药量进行测定评价,并考察表面活性剂对纳米粒包封率、载药量及得率的影响。结果和结论:层析-离心法测定结果可靠。亲水性表面活性剂0.3%洛泊沙姆和亲脂性表面活性剂0·48%卵磷脂联合使用,有利于高水溶性药物的包封,包封率为28.42%,载药量为10.5%。 Objective: To prepare the highly water-soluble drug (HWS-drug) bovine serum albumin nanoparticles, and study the effects of surfactants on them. Methods: Sodium ferulate bovine serum albumin nanoparticles (SF-BSA-NP) were prepared from sodium ferulate (SF), which was a HWS-drug, and bovine serum albumin (BSA) by desolvation method. Using the methods of ultracentrifugation, chromatography-ultracentrifugation and chromatography-trypsin degradation, the entrapment efficiency and drug loading of SF-BSA-NP were determined, respectively. The effects of surfactants on the entrapment efficiency and drug loading were studied. Results and Conclusion: The entrapment efficiency and drug loading measured by the method of chromatography-ultracentrifugation were reliable. Hydrophilic surfactant together with lipophilic surfactant could benefit the preparation of HWS-drug bovine serum albumin nanoparticles. The entrapment efficiency was 28.42% and drug loading was 10.5%.
出处 《药学服务与研究》 CAS CSCD 2005年第2期153-156,共4页 Pharmaceutical Care and Research
基金 国家自然科学基金资助项目(30371701) 上海市纳米技术专项课题(0452nm083)
关键词 牛血清白蛋白 纳米粒 阿魏酸钠 表面活性剂 去溶剂化法 bovine serum albumin nanoparticle sodium ferulate surfactant desolvation
  • 相关文献

参考文献9

二级参考文献44

  • 1邢纪中,张俊义,肖建宇,李文录,贾炜莹.碘油混合乳剂栓塞术治疗晚期肾癌[J].中国肿瘤临床,1996,23(12):870-872. 被引量:9
  • 2[1]Alcolado R, Arthur MJ, Iredale JP. Pathogenesis of liver fibrosis[J]. Clin Sci, 1997, 92(2):103.
  • 3张万国,胡晋红.中药抗肝纤维化机制研究新进展[J].中草药,2000,31(增刊):175.
  • 4[6]Han T, Qian SC, Li B, et al. Anti-fibrotic effect of Chinese traditional drug (CMBD) on liver fibrosis in rat [J]. J Gastroenterol Hepatol, 1993, 8(2):194.
  • 5[25]Yao T,Huang L,Zern MA.The use of liposomes in the therapy of liver disease[J].Adv Drug Del Rev.1995,17(3):239.
  • 6Friedman SL. The cellular basis of hepatic fibeosis [ J ].N Engl J Med, 1993,328(25) :1828 - 1835.
  • 7Garcia-Trevijano ER, Iraburu MJ, Fontana L, et al.Transforming growth factor β1 induces the expression of α (I) procollagen mRNA by a hydrogen peroxide-C/EBPβdependent mechanism in rat hepatic stellate cells [ J ].Hepatology, 1999,29 (3) :960 - 970.
  • 8Greenwel P, Dominguea-Rosales JA, Mavi GA, et al.Hydrogen peroxide: A link between acetaldehyde-Elicited α1 (I) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells [ J ]. Hepatology, 2000,31(1) :109 -116.
  • 9JiYP HuJH LiuT etal.Protection of sodium ferulate on acute hepatic injure of mice .Acnd J Second Mil Mel Univ(第二军医大学学报),2000,21(10):996-998.
  • 10LiY HanBL LiK etal.Measuring bioactive TGF—β1by cell growth inhibition .Acta Acad Mel Mil Tert (第三军医大学学报),1999,21(2):138-140.

共引文献33

同被引文献28

引证文献3

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部